Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Glutamine × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3 Peripheral Nervous System Diseases 2 Head and Neck Neoplasms 2 Vaso-Occlusive Crises 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Pain 1 Mucositis 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Fluorouracil 117 Leucovorin 110 Oxaliplatin 84 Bevacizumab 74 Irinotecan 66 Capecitabine 58 Cetuximab 37 Folfox protocol 30 Panitumumab 16 regorafenib 13 Drug Therapy 13 trifluridine tipiracil drug combination 12 Chemotherapy, Adjuvant 11 IFL protocol 9 Radiotherapy 8 Floxuridine 8 Neoadjuvant Therapy 7 Aspirin 7 pembrolizumab 5 XELOX 5 Mitomycin 5 Levoleucovorin 5 Laparoscopy 5 dehydroftorafur 4 atezolizumab 4 Trifluridine 4 S 1 (combination) 4 Octreotide 4 Magnetic Resonance Spectroscopy 4 Levamisole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01087658 2013-06-21

GLUTOX

Sanofi

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡